Literature DB >> 9105846

Evaluation of rapid molecular methods for detection of clarithromycin resistance in Helicobacter pylori.

F Szczebara1, L Dhaenens, P Vincent, M O Husson.   

Abstract

Resistance of Helicobacter pylori to clarithromycin is due to point mutations at position A2143 or A2144 of the rrnH 23S rRNA gene, each mutation creating an additional restriction site for BsaI or MboII. A procedure combining PCR and RFLP analysis was evaluated for detection of these mutations using primers specific for the 23S rRNA gene, and BsaI and MboII enzymes. All clarithromycin-resistant isolates (8/8), as defined by the MIC, were found to be resistant by PCR-RFLP. No clarithromycin-sensitive isolates (14/14) gave a positive reaction.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9105846     DOI: 10.1007/bf01709478

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  11 in total

1.  Risks related to lack of standardization of tests to detect in vitro metronidazole resistance in Helicobacter pylori.

Authors:  T H Henriksen; O Brorson; R Schöyen; T Thoresen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

2.  Antimicrobial resistance and Helicobacter pylori.

Authors:  A F Goddard; R P Logan
Journal:  J Antimicrob Chemother       Date:  1996-04       Impact factor: 5.790

3.  Short-term low-dose triple therapy with lansoprazole plus amoxycillin and clarithromycin for Helicobacter pylori eradication.

Authors:  A Tursi; G Cammarota; A Papa; M Montalto; G Fedeli; G Gasbarrini
Journal:  Am J Gastroenterol       Date:  1996-08       Impact factor: 10.864

4.  Clarithromycin resistance in Helicobacter pylori: prevalence in untreated dyspeptic patients and stability in vitro.

Authors:  H X Xia; M Buckley; C T Keane; C A O'Morain
Journal:  J Antimicrob Chemother       Date:  1996-03       Impact factor: 5.790

Review 5.  Erythromycin resistance by ribosome modification.

Authors:  B Weisblum
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

6.  Antimicrobial susceptibility testing of Helicobacter pylori. Comparison of E-test, broth microdilution, and disk diffusion for ampicillin, clarithromycin, and metronidazole.

Authors:  C Y Hachem; J E Clarridge; R Reddy; R Flamm; D G Evans; S K Tanaka; D Y Graham
Journal:  Diagn Microbiol Infect Dis       Date:  1996-01       Impact factor: 2.803

7.  Identification of mutations in 23S rRNA gene of clarithromycin-resistant Mycobacterium intracellulare.

Authors:  A Meier; P Kirschner; B Springer; V A Steingrube; B A Brown; R J Wallace; E C Böttger
Journal:  Antimicrob Agents Chemother       Date:  1994-02       Impact factor: 5.191

8.  Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori.

Authors:  J Versalovic; D Shortridge; K Kibler; M V Griffy; J Beyer; R K Flamm; S K Tanaka; D Y Graham; M F Go
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

9.  Site of action of a ribosomal RNA methylase responsible for resistance to erythromycin and other antibiotics.

Authors:  R Skinner; E Cundliffe; F J Schmidt
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

10.  Results of a multicentre European survey in 1991 of metronidazole resistance in Helicobacter pylori. European Study Group on Antibiotic Susceptibility of Helicobacter pylori.

Authors: 
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

View more
  11 in total

1.  PCR using 3'-mismatched primers to detect A2142C mutation in 23S rRNA conferring resistance to clarithromycin in Helicobacter pylori clinical isolates.

Authors:  T Alarcón; D Domingo; N Prieto; M López-Brea
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Rapid and accurate determination of genotypic clarithromycin resistance in cultured Helicobacter pylori by fluorescent in situ hybridization.

Authors:  H Rüssmann; K Adler; R Haas; B Gebert; S Koletzko; J Heesemann
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

3.  Rapid PCR detection of Helicobacter pylori-associated virulence and resistance genes directly from gastric biopsy material.

Authors:  B Björkholm; R Befrits; B Jaup; L Engstrand
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

4.  Mutations in 23S rRNA in Helicobacter pylori conferring resistance to erythromycin do not always confer resistance to clarithromycin.

Authors:  M I García-Arata; F Baquero; L de Rafael; C Martín de Argila; J P Gisbert; F Bermejo; D Boixeda; R Cantón
Journal:  Antimicrob Agents Chemother       Date:  1999-02       Impact factor: 5.191

5.  Simultaneous colonisation of Helicobacter pylori with and without mutations in the 23S rRNA gene in patients with no history of clarithromycin exposure.

Authors:  M Matsuoka; Y Yoshida; K Hayakawa; S Fukuchi; K Sugano
Journal:  Gut       Date:  1999-10       Impact factor: 23.059

6.  Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation.

Authors:  K Trebesius; K Panthel; S Strobel; K Vogt; G Faller; T Kirchner; M Kist; J Heesemann; R Haas
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

Review 7.  Molecular testing for antibiotic resistance in Helicobacter pylori.

Authors:  R J Owen
Journal:  Gut       Date:  2002-03       Impact factor: 23.059

Review 8.  Basis for the management of drug-resistant Helicobacter pylori infection.

Authors:  Francis Mégraud
Journal:  Drugs       Date:  2004       Impact factor: 9.546

9.  Macrolide resistance in microorganisms at antimicrobial-free Swine farms.

Authors:  Zhi Zhou; Lutgarde Raskin; Julie L Zilles
Journal:  Appl Environ Microbiol       Date:  2009-07-24       Impact factor: 4.792

10.  Detection of point mutations associated with resistance of Helicobacter pylori to clarithromycin by hybridization in liquid phase.

Authors:  M Pina; A Occhialini; L Monteiro; H P Doermann; F Mégraud
Journal:  J Clin Microbiol       Date:  1998-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.